Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opdivo
Pharma
BMS shoots for 1L liver cancer again with Opdivo, Yervoy combo
If approved by the FDA, BMS' Opdivo-Yervoy combo will go toe to toe with Roche's and AstraZeneca's immunotherapies in first-line liver cancer.
Angus Liu
Mar 20, 2024 10:18am
Merck claims digital crown, holding off challenge from AZ, BMS
Mar 15, 2024 10:30am
BMS, overshadowed by ADC rival, wins FDA nod in 1L bladder cancer
Mar 8, 2024 9:56am
BMS CEO outlines transition strategy featuring 11 brands, BD
Feb 2, 2024 11:30am
BMS touts latest Opdivo data as I-O battle heads to new front
Jan 29, 2024 8:45am
Merck celebrates trial win, while Bristol fails in kidney cancer
Jan 27, 2024 10:00am